News Snapshot:
SHANGHAI — Shares in one of China's largest traditional medicine producers plunged on Monday (April 18) after reports questioned the efficacy of pills approved by the government as a coronavirus treatment. Shanghai authorities have joined their Hong Kong counterparts in handing out “Lianhua Qingwen” — a herbal remedy marketed for fever and sore throats — as the cities battle their worst Covid-19 outbreaks since the pandemic's start. But on Sunday, popular Chinese health platform Dingxiang Yisheng said the capsules, made by Shijiazhuang Yiling Pharmaceutical, could not prevent cases of the virus, in a report then picked up by state media....
